<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01808378</url>
  </required_header>
  <id_info>
    <org_study_id>HULPOFT-2010-01</org_study_id>
    <secondary_id>2010-024328-53</secondary_id>
    <nct_id>NCT01808378</nct_id>
  </id_info>
  <brief_title>Stem Cells Treatment for Bilateral Limbic Associated Keratopathy (HULPOFT)</brief_title>
  <acronym>HULPOFT</acronym>
  <official_title>Phase IIa Clinical Trial to Study the Feasability and Security of the Expanded Autologous Stem Cells (ASC) From Lipoaspirate in the Bilateral Limbic Associated Keratopathy Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the use of the autologous ASC for the treatment of bilateral limbic associated
      keratopathy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intralesional use by inject of adipose derived stem cells
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the practicability and security of the autologous expanded lipoaspirated stem cells for the treatment of bilateral limbic associated keratopathy</measure>
    <time_frame>16 weeks</time_frame>
    <description>Micro ocular Photography Visual acuity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment using the SF-12 Questionnaire</measure>
    <time_frame>1, 4, 16, 24 weeks</time_frame>
    <description>SF-12 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1, 4, 16, 24 weeks</time_frame>
    <description>Data collection</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Keratopathy</condition>
  <arm_group>
    <arm_group_label>Autologous Stem Cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Autologous expanded adipose-derived stem cells</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Expanded adipose-derived stem cells</intervention_name>
    <description>Local injection of autologousadipose derived stem cells</description>
    <arm_group_label>Autologous Stem Cells</arm_group_label>
    <other_name>ASC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. -Signed informed consent

          2. -Previously diagnosed bilateral limbic obstruction

          3. -Men and women over 18 years old. Good general state of health according to the
             findings of the clinical history and the physical examination

          4. -Suffering chronic keratopathy accomplishing the following criteria:

               -  Confirmed limbic obstruction with an impression cytology

               -  Repeated usual treatment failure for this pathology

        Exclusion Criteria:

          1. -Having suffered a neoplasia in the previous 5 years

          2. -Local anesthesia allergies

          3. -Patients having participate in any other study in the previous 90 days to the
             inclusion

          4. -Patients on medication with tacrolimus or cyclosporine in the 4 previous week to the
             cellular therapy

          5. -Any medical or psychiatric illness that, in the investigator opinion, could suppose a
             reason for the study exclusion

          6. -Patients with any type of medical or psychiatric disease which, in the opinion of the
             investigator, could be grounds for exclusion from study

          7. -Patients with congenital or acquired immunodeficiencies. HIV, HBV, HCV or treponema
             infection, whether active or latent

          8. -Patients who have suffering major surgery or severe trauma in the prior 6 months

          9. -Pregnant or breastfeeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana Boto de los Bueis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Paz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariano García-Arranz, PhD</last_name>
    <phone>0034 912071022</phone>
    <email>mgarciaa.hulp@salud.madrid.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana Boto de los Bueis, MD</last_name>
    <phone>0034 912071022</phone>
    <email>mgarciaa.hulp@salud.madrid.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariano García-Arranz, PhD</last_name>
      <phone>0034 912071022</phone>
      <email>mgarciaa.hulp@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Ana Boto de los Bueis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariano García-Arranz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Almudena del Hierro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nerea Saenz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Nishida K. Tissue engineering of the cornea. Cornea. 2003 Oct;22(7 Suppl):S28-34. Review.</citation>
    <PMID>14703705</PMID>
  </reference>
  <reference>
    <citation>Arntz Bustos A, Durán de la Colina JA. Anatomía funcional de la superficie ocular. En; Superficie Ocular. Ed S.E.O. 2004; 1-12</citation>
  </reference>
  <reference>
    <citation>Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol. 1986 Jul;103(1):49-62.</citation>
    <PMID>2424919</PMID>
  </reference>
  <reference>
    <citation>Tseng SC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 1985 Jun;92(6):728-33.</citation>
    <PMID>3897935</PMID>
  </reference>
  <reference>
    <citation>Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989 May;96(5):709-22; discussion 722-3.</citation>
    <PMID>2748125</PMID>
  </reference>
  <reference>
    <citation>Santos MS, Gomes JA, Hofling-Lima AL, Rizzo LV, Romano AC, Belfort R Jr. Survival analysis of conjunctival limbal grafts and amniotic membrane transplantation in eyes with total limbal stem cell deficiency. Am J Ophthalmol. 2005 Aug;140(2):223-30.</citation>
    <PMID>16023069</PMID>
  </reference>
  <reference>
    <citation>Chen JJ, Tseng SC. Corneal epithelial wound healing in partial limbal deficiency. Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1301-14.</citation>
    <PMID>1694836</PMID>
  </reference>
  <reference>
    <citation>Tan DT, Ficker LA, Buckley RJ. Limbal transplantation. Ophthalmology. 1996 Jan;103(1):29-36.</citation>
    <PMID>8628556</PMID>
  </reference>
  <reference>
    <citation>Samson CM, Nduaguba C, Baltatzis S, Foster CS. Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology. 2002 May;109(5):862-8.</citation>
    <PMID>11986089</PMID>
  </reference>
  <reference>
    <citation>Tsubota K, Toda I, Saito H, Shinozaki N, Shimazaki J. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology. 1995 Oct;102(10):1486-96.</citation>
    <PMID>9097796</PMID>
  </reference>
  <reference>
    <citation>Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology. 2002 Jul;109(7):1278-84.</citation>
    <PMID>12093650</PMID>
  </reference>
  <reference>
    <citation>Pellegrini G, De Luca M, Arsenijevic Y. Towards therapeutic application of ocular stem cells. Semin Cell Dev Biol. 2007 Dec;18(6):805-18. Epub 2007 Sep 16. Review.</citation>
    <PMID>17959397</PMID>
  </reference>
  <reference>
    <citation>Inatomi T, Nakamura T, Koizumi N, Sotozono C, Yokoi N, Kinoshita S. Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. Am J Ophthalmol. 2006 Feb;141(2):267-275.</citation>
    <PMID>16458679</PMID>
  </reference>
  <reference>
    <citation>Yao YF, Inoue Y, Miyazaki K, Shimoura Y, Ohashi Y, Tano Y. Ocular resurfacing and alloepithelial suface reconstruction. Ophthalmol 2005; 112: 470-7</citation>
  </reference>
  <reference>
    <citation>Daya SM, Watson A, Sharpe JR, Giledi O, Rowe A, Martin R, James SE. Outcomes and DNA analysis of ex vivo expanded stem cell allograft for ocular surface reconstruction. Ophthalmology. 2005 Mar;112(3):470-7.</citation>
    <PMID>15745776</PMID>
  </reference>
  <reference>
    <citation>Nakamura T, Kinoshita S. Ocular surface reconstruction using cultivated mucosal epithelial stem cells. Cornea. 2003 Oct;22(7 Suppl):S75-80.</citation>
    <PMID>14703711</PMID>
  </reference>
  <reference>
    <citation>Nakamura T, Inatomi T, Sotozono C, Amemiya T, Kanamura N, Kinoshita S. Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br J Ophthalmol. 2004 Oct;88(10):1280-4.</citation>
    <PMID>15377551</PMID>
  </reference>
  <reference>
    <citation>Nishida K, Yamato M, Hayashida Y, Watanabe K, Yamamoto K, Adachi E, Nagai S, Kikuchi A, Maeda N, Watanabe H, Okano T, Tano Y. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med. 2004 Sep 16;351(12):1187-96.</citation>
    <PMID>15371576</PMID>
  </reference>
  <reference>
    <citation>Lehrer MS, Sun TT, Lavker RM. Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J Cell Sci. 1998 Oct;111 ( Pt 19):2867-75.</citation>
    <PMID>9730979</PMID>
  </reference>
  <reference>
    <citation>Ma Y, Xu Y, Xiao Z, Yang W, Zhang C, Song E, Du Y, Li L. Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells. 2006 Feb;24(2):315-21. Epub 2005 Aug 18.</citation>
    <PMID>16109757</PMID>
  </reference>
  <reference>
    <citation>Blazejewska EA, Schlötzer-Schrehardt U, Zenkel M, Bachmann B, Chankiewitz E, Jacobi C, Kruse FE. Corneal limbal microenvironment can induce transdifferentiation of hair follicle stem cells into corneal epithelial-like cells. Stem Cells. 2009 Mar;27(3):642-52. doi: 10.1634/stemcells.2008-0721.</citation>
    <PMID>19074417</PMID>
  </reference>
  <reference>
    <citation>Gu S, Xing C, Han J, Tso MO, Hong J. Differentiation of rabbit bone marrow mesenchymal stem cells into corneal epithelial cells in vivo and ex vivo. Mol Vis. 2009;15:99-107. Epub 2009 Jan 16.</citation>
    <PMID>19156227</PMID>
  </reference>
  <reference>
    <citation>Arnalich-Montiel F, Pastor S, Blazquez-Martinez A, Fernandez-Delgado J, Nistal M, Alio JL, De Miguel MP. Adipose-derived stem cells are a source for cell therapy of the corneal stroma. Stem Cells. 2008 Feb;26(2):570-9. Epub 2007 Dec 6.</citation>
    <PMID>18065394</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2012</study_first_submitted>
  <study_first_submitted_qc>March 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2013</study_first_posted>
  <last_update_submitted>March 7, 2013</last_update_submitted>
  <last_update_submitted_qc>March 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bilateral limbic associated keratopathy</keyword>
  <keyword>Expanded Adipose Derived Stem Cells</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

